The Brilliance NT2 Study is now enrolling adults living with narcolepsy type 2 (NT2) to research if an investigational study drug – a medication that is still being researched and is not approved for general use – may be a potential treatment option for excessive daytime sleepiness (EDS).

If you experience EDS due to narcolepsy type 2, talk to your doctor and visit BrillianceStudies.com or contact Summer Moore at 478-745-5779 ext 1004 to learn more.